Health
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 | FDA – FDA.gov
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
For Immediate Release:
June 04, 2021
Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. This under-the-skin injection is the first approved drug for chronic weight management in adults with…
-
Noosa News20 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Noosa News20 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
General17 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business21 hours ago16 ASX 200 shares roar to multi-year highs amid new market milestone